PHOSPHOUT 400MG

About

PHOSPHOUT 400MG is a phosphate binder medication primarily used in patients with chronic kidney disease (CKD) who are on dialysis. Its active ingredient works by binding to dietary phosphate in the gastrointestinal tract, forming insoluble complexes that are then excreted in the feces. This action prevents the absorption of phosphate into the bloodstream, thereby helping to control hyperphosphatemia, a common and serious complication of CKD. Uncontrolled hyperphosphatemia can lead to secondary hyperparathyroidism, renal osteodystrophy, and increased cardiovascular risk. PHOSPHOUT 400MG is an essential part of the comprehensive management strategy for maintaining mineral and bone balance in dialysis patients, contributing to improved long-term health outcomes.

Uses

• Management of hyperphosphatemia in CKD patients
• Control of serum phosphate levels in dialysis patients
• Prevention of secondary hyperparathyroidism
• Reduction of cardiovascular risk associated with high phosphate

Directions For Use

Take orally with meals. Dosage is individualized based on serum phosphate levels and dietary phosphate intake.

Benefits

• Effectively lowers serum phosphate levels
• Reduces the risk of renal osteodystrophy
• Helps prevent secondary hyperparathyroidism
• Contributes to improved cardiovascular health
• Easy oral administration with meals
• Essential for mineral and bone disorder management in CKD

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Dyspepsia (indigestion)
• Flatulence
• Metallic taste
• Hypophosphatemia (if over-dosed)
• Hypercalcemia (with calcium-based binders)
• Intestinal obstruction (rare)
• Allergic reactions (rare)

Safety Measures

• Alcohol - Alcohol consumption should be limited or avoided as it can exacerbate gastrointestinal side effects and may interfere with overall nutritional status in CKD patients.
• Pregnancy - Consult a doctor before use during pregnancy. The risks and benefits must be carefully weighed, and phosphate levels should be closely monitored.
• Breastfeeding - Consult a doctor before use during breastfeeding. It is generally considered safe, but monitoring of infant's mineral levels may be advised.
• Liver - Generally safe for use in patients with liver conditions, but caution is advised if severe hepatic impairment is present, as it may affect overall metabolism and drug interactions.
• Kidney - PHOSPHOUT 400MG is specifically indicated for patients with chronic kidney disease, particularly those on dialysis, to manage hyperphosphatemia.
• Lung - No specific contraindications or precautions related to lung conditions, but overall patient health and potential drug interactions should always be considered.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.